🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to confirm the efficacy, safety, pha...
Status
Not Yet Recruiting
Location
Research Site
Start Date
2026-08-31
Trial ID
NCT07557420
Treatments Being Tested
This study evaluated the safety and tolerability of a single dose of ALXN12...
Status
Completed
Location
Clinical Trial Site
Start Date
2016-08-19
Trial ID
NCT05288829
Treatments Being Tested
The primary purpose of this study is to evaluate the safety, tolerability, ...
Status
Completed
Location
Clinical Trial Site
Start Date
2016-01-04
Trial ID
NCT02605993
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of ravulizu...
Status
Completed
Location
Research Site
Start Date
2024-10-10
Trial ID
NCT06578949
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, pharmacoki...
Status
Completed
Location
Omeros Investigational Site
Start Date
2023-03-27
Trial ID
NCT05972967
Treatments Being Tested
The primary purpose of this study was to assess the noninferiority of ravul...
Status
Completed
Location
Research Site
Start Date
2016-12-12
Trial ID
NCT02946463
Treatments Being Tested
This study evaluated the safety and tolerability of multiple doses of ALXN1...
Status
Completed
Location
Clinical Trial Site
Start Date
2015-07-28
Trial ID
NCT05288673
This study evaluated the safety, tolerability, pharmacokinetics (PK) and ph...
Status
Completed
Location
Clinical Trial Site
Start Date
2014-08-27
Trial ID
NCT05288660
The primary purpose of this study is to evaluate the efficacy and safety of...
Status
Completed
Location
Research Site
Start Date
2019-12-09
Trial ID
NCT04201262
Treatments Being Tested
The primary purpose of this study is to characterize the pharmacokinetics a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-06-24
Trial ID
NCT05644561
Treatments Being Tested